What is the difference between GDP and GMP?

GMP (Good Manufacturing Practice) governs the quality and safety of the manufacturing of medicinal products, up to and including batch release by the Qualified Person (QP). GDP (Good Distribution Practice, EU Guideline 2013/C 343/01) governs quality during storage, transport and distribution of medicinal products, from batch release to the patient or healthcare provider. Both require a validated quality system with a full audit trail in line with 21 CFR Part 11 (for the US market) or the EU GMP/GDP requirements. A pharmaceutical manufacturer typically needs both certifications; a wholesaler or logistics provider only needs GDP.

Key Points

• GMP: quality assurance during manufacturing, up to batch release
• GDP: quality assurance during storage and transport, after batch release
• Legal framework: EU Guideline 2013/C 343/01 (GDP) and EudraLex Volume 4 (GMP)
• Audit trail required per 21 CFR Part 11 / EU Annex 11
• Pharma manufacturers: need both GMP and GDP certification; wholesalers/carriers: GDP only
• HECHT equipment is designed to be GMP-compliant; for GDP-compliant storage and containment, HECHT supplies supporting systems

Why the Difference Between GDP and GMP Matters

A medicinal product manufactured flawlessly under GMP can still become unsafe if the GDP chain fails after production: a broken cold chain, a non-validated carrier, or a gap in anti-counterfeiting protection undermines the quality built up during manufacturing. Regulators therefore assess GMP and GDP as two separate, equally important links in the same chain. For manufacturers, wholesalers and logistics providers, this means two distinct certification pathways with their own audits, responsible persons, and documentation requirements.

GDP and GMP in Practice: Step by Step

1. Manufacturing under GMP: raw materials, in-process control and final product testing up to release by the Qualified Person.
2. Handover point: batch release marks the transition from GMP responsibility to GDP responsibility.
3. Storage under GDP: temperature-controlled storage, validated warehouses, first-expiry-first-out management.
4. Transport under GDP: qualified carriers, temperature monitoring with data loggers, excursion management protocols for deviations.
5. Distribution and delivery: FMD (Falsified Medicines Directive) verification upon delivery to pharmacy or healthcare institution, full documentation returned to the Responsible Person.

Practical Scenarios

• Continuous manufacturing of medicines: with continuous rather than batch-wise production, the GMP/GDP handover point shifts to real-time release per production unit — this places higher demands on automated quality control and documentation (see also our continuous manufacturing reference case at Pfizer).
• Cold chain for vaccines and biologics: storage and transport between 2–8°C is a GDP requirement, maintained with real-time data loggers and a documented excursion protocol.
• HPAPI and containment-sensitive products: GMP requirements for containment (see our containment systems guide) carry through into GDP requirements for packaging and transport security.

Benefits of a Clear GMP/GDP Separation

• Clear division of responsibility between manufacturing and logistics partners
• Shorter audit times because quality dossiers are separated by phase and complete
• Lower risk of product recalls through timely detection of cold-chain deviations
• Easier to demonstrate compliance to regulators and customers

Frequently Asked Questions (FAQ)

How does GDP differ from GMP in one sentence?

GMP safeguards quality during manufacturing up to batch release; GDP safeguards quality during storage and transport after batch release, all the way to the patient.

Who is responsible for GDP?

Wholesalers and carriers of medicinal products. For pharma manufacturers, GDP applies from the moment of batch release.

What are the core requirements of GDP?

Temperature monitoring, a designated Responsible Person for distribution, FMD anti-counterfeiting verification, validated carriers, and a complete audit trail.

What are the cold-chain implications of GDP?

For vaccines and biologics, this is typically 2–8°C, maintained with real-time data loggers and a mandatory excursion management protocol for temperature deviations.

Can a company be GDP-certified only, without GMP?

Yes. Wholesalers, distributors and logistics providers that do not manufacture medicinal products only need GDP certification.

Conclusion

GMP and GDP are complementary, not synonymous: GMP safeguards quality up to release, GDP safeguards quality afterward. For pharmaceutical manufacturers that distribute their own products, a seamless handover between both systems is essential — and that starts with equipment and containment solutions that already meet the stricter GMP requirements from the point of manufacture.

About the Author

Joost van Velzen is Managing Director and co-shareholder of HECHT Technology B.V., the Dutch branch of the HECHT group. With over 20 years of experience in the process industry, he guides pharmaceutical, chemical and food producers in selecting and implementing GMP-compliant containment and bulk-handling systems. More information via LinkedIn.

Hecht Technology: GMP-certified process equipment

GMP compliance starts with the process equipment itself. Hecht Technology supplies GMP-certified systems such as the single-use isolator, which prevents cross-contamination and supports full traceability — essential for manufacturers who need to meet GMP requirements in the production process.

Our products

• Single-use isolator